208774-11-2 Usage
Uses
Used in Pharmaceutical Synthesis:
1H-Indole-1,4-dicarboxylic acid,2,3-dihydro-,1-(1,1-dimethylethyl) ester is used as a building block in the synthesis of various pharmaceuticals. Its unique structure allows for the creation of a wide range of therapeutic agents, contributing to the development of new medications.
Used in Agrochemical Development:
1H-INDOLE-1,4-DICARBOXYLIC ACID,2,3-DIHYDRO-,1-(1,1-DIMETHYLETHYL)ESTER is also utilized in the synthesis of agrochemicals, playing a role in the development of products designed to enhance crop protection and improve agricultural yields.
Used in Organic Compound Synthesis:
Due to its versatile chemical properties, 1H-Indole-1,4-dicarboxylic acid,2,3-dihydro-,1-(1,1-dimethylethyl) ester is employed in the synthesis of a variety of organic compounds, expanding the scope of chemical research and applications.
Used in Medicinal Chemistry Research:
The indole ring structure of 1H-INDOLE-1,4-DICARBOXYLIC ACID,2,3-DIHYDRO-,1-(1,1-DIMETHYLETHYL)ESTER makes it a promising candidate for medicinal chemistry research. It is used in the exploration of new drug candidates and the advancement of drug development processes.
Check Digit Verification of cas no
The CAS Registry Mumber 208774-11-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,8,7,7 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 208774-11:
(8*2)+(7*0)+(6*8)+(5*7)+(4*7)+(3*4)+(2*1)+(1*1)=142
142 % 10 = 2
So 208774-11-2 is a valid CAS Registry Number.
InChI:InChI=1S/C14H17NO4/c1-14(2,3)19-13(18)15-8-7-9-10(12(16)17)5-4-6-11(9)15/h4-6H,7-8H2,1-3H3,(H,16,17)
208774-11-2Relevant articles and documents
HIV PROTEASE INHIBITORS, COMPOSITIONS CONTAINING THE SAME AND THEIR PHARMACEUTICAL USES
-
Page/Page column 99, (2010/02/11)
This invention relates to a novel series of chemical compounds useful as Human immunodeficiency Virus (HIV) protease inhibitors and to the use of such compounds as antiviral agents. The invention further relates to pharmaceutical compositions containing s
Benzamide derivatives having a vasopressin antagonistic activity
-
, (2008/06/13)
This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc. and represented by general formula (I): wherein R1is aryl optionally substituted with lower alkoxy, etc., R2is lower alkyl, etc., R3is hydrogen, etc., A is NH, etc., E is etc., X is —CH═CH—, —CH═N—, or S, and Y is a condensed heterocyclic group, etc., and pharmaceutically acceptable salts thereof, to processes for preparation thereof and to a pharmaceutical composition comprising the same.
